Using stem cells to create cartilage for joint repair
Articular Cartilage Tissue Engineering with Human Pluripotent Stem Cells
This study is exploring new ways to create healthy cartilage from human stem cells to help repair damaged joints, especially for people with osteoarthritis, by making it more like the natural cartilage in our bodies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Steadman Philippon Research Institute NIH-funded |
| Lab location | 1 site (Vail, United States) |
| Project ID | NIH-11063158 on NIH RePORTER |
What this research studies
This research focuses on developing new methods to engineer articular cartilage using human pluripotent stem cells. The team aims to identify the molecular targets that influence the formation of permanent cartilage, which is crucial for repairing damaged joints, particularly in conditions like osteoarthritis. By utilizing specialized cells derived from stem cells, the research seeks to create cartilage that closely resembles natural joint cartilage, avoiding issues seen with current therapies. The approach includes in vitro chondrogenesis and transplantation of the engineered cartilage to assess its effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults suffering from joint injuries or osteoarthritis who are seeking innovative treatment options.
Not a fit: Patients with advanced osteoarthritis or those who have already undergone multiple joint surgeries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for joint injuries and osteoarthritis, improving mobility and quality of life for patients.
How similar studies have performed: While tissue engineering for cartilage repair has been explored, this specific approach using human pluripotent stem cells is relatively novel and has not been extensively tested.
Where this research is happening
Vail, United States
- Steadman Philippon Research Institute — Vail, United States (Active)
Researchers
- Principal investigator: Nakayama, Naoki — Steadman Philippon Research Institute
- Study coordinator: Nakayama, Naoki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.